Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Drug Prices
Trump Administration Issues Most Favored Nation Model
On Friday, November 20, 2020, United States President Donald Trump and the Centers for Medicare and Medicaid Services (CMS)…
Trump Administration Finalizes Drug Importation Rule
Earlier this year, the Trump Administration released a final rule focused on allowing states and others to establish programs to…
New Brief Shows Mandated Drug Rebates Benefit Patients
A new brief released in September by the Center for Medical Economics and Innovation at the Pacific Research Institute found that…
CMS Proposed Hospital Outpatient Prospective Payment System Rule Calls for…
05The Department of Health and Human Services (HHS) Centers for Medicare and Medicaid Services (CMS) published the 2021 Hospital…
President Trump Signs “Most Favored Nation Price” Executive Order on Drug…
On September 13, 2020, United States President Donald Trump signed an Executive Order (EO) to create a “most favored nation” drug…
California Getting into the Generic Drug Business?
Earlier this month, California’s state legislature approved a bill that would allow the state to be the first state to develop its…
House Oversight Committee Subpoenas AbbVie in Drug Pricing Probe
On September 1, 2020, Carolyn B. Maloney, Chairwoman of the United States House of Representatives Committee on Oversight and…
Drug Pricing Policy Update – Election Uncertainty & Questions about…
As the current pandemic continues to dominate the current news cycle, the high costs of drugs remains an important issue for the…
Bausch Health (FKA Valeant Pharmaceuticals) Agrees to $45 Million SEC…
Earlier this year, the United States Securities and Exchange Commission (SEC) announced a settlement with Bausch Health (formerly…
Teva to be First Target in Generic Price-Fixing Suit
In July 2020, a Philadelphia judge ruled that Teva Pharmaceutical Industries Ltd. will be the first trial to advance in the…